Note D - Marketable Equity Securities |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2026 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Notes to Financial Statements | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Investment in Debt and Equity Securities and Other Trading Assets [Text Block] |
NOTE D: MARKETABLE EQUITY SECURITIES The Company’s investments in marketable securities consist of equity securities with readily determinable fair values. The cost of securities sold is based on the specific identification method, and interest and dividends on securities are included in non-operating income (expense).
Marketable equity securities are carried at fair value, with gains and losses in fair market value included in the determination of net income. The fair value of marketable equity securities is determined based on quoted market prices in active markets, as described in Note J.
The following table sets forth market value, cost, and unrealized gains on equity securities as of March 31, 2026 and December 31, 2025.
The following table sets forth the gross unrealized gains and losses on the Company’s marketable securities as of March 31, 2026 and December 31, 2025.
The following table shows the Company’s net realized gains during the three months ending on March 31, 2026 and 2025, respectively, on certain marketable equity securities.
For the quarter ended March 31, 2026, the Company recognized dividends received of approximately $426,000 in non-operating income in its condensed consolidated statements of operations. For the quarter ended March 31, 2025, the Company recognized dividends received of approximately $443,000 in non-operating income in its condensed consolidated statements of operations.
The Company’s equity securities are periodically used as collateral against any outstanding margin account borrowings. As of March 31, 2026, the Company had no outstanding borrowings under its margin account, which is no change from December 31, 2025, when the Company had no outstanding borrowings under the same account. Margin account borrowings, when utilized, are used for the purchase of marketable equity securities and as a source of short-term liquidity and are included in accrued expenses and other liabilities on our condensed consolidated balance sheets.
Our marketable equity securities portfolio had a net unrealized pre-tax loss in market value of approximately $1,626,000 during the first quarter of 2026, and a net unrealized pre-tax gain in market value of approximately $1,316,000 during the first quarter of 2025, which were reported as non-operating income in its condensed consolidated statements of operations for the respective periods. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||